Source: Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Wenying Lu, Pawan Sharma, Mathew Suji Eapen, Sukhwinder Singh Sohal. Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis. Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019

Member's Comments

No comment yet.

Related content which might interest you: Inhaled corticosteroid use and the incidence of lung cancer in COPD Source: Eur Respir J, 55 (2) 1901720; 10.1183/13993003.01720-2019 Year: 2020 Inhaled corticosteroids (ICS) attenuates epithelial mesenchymal transition (EMT) in COPD: A key to understanding long term benefits? Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1211-1212 Year: 2014 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1208-1211 Year: 2014 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2013; 42: 350-361 Year: 2013 Inhaled furosemide & lung epithelial permeability: an added dimension to asthma therapy Source: Eur Respir J 2001; 18: Suppl. 33, 424s Year: 2001 The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD Source: Eur Respir J, 54 (6) 1900521; 10.1183/13993003.00521-2019 Year: 2019 Inhaled corticosteroids and the growth of lung function in children Source: Eur Respir J 2004; 23: 795-796 Year: 2004 Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD Source: Eur Respir J, 53 (6) 1900717; 10.1183/13993003.00717-2019 Year: 2019 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019 Year: 2019 Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006 Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules Source: Eur Respir J, 51 (2) 1702257; 10.1183/13993003.02257-2017 Year: 2018 Features of endothelial dysfunction at the patients with bronchial asthma treated by oral glucocorticoids Source: Eur Respir J 2002; 20: Suppl. 38, 480s Year: 2002